United States Pathology Market was valued at USD 18.5 Billion in 2022 and is projected to reach USD 25.4 Billion by 2030, growing at a CAGR of 4.3% from 2024 to 2030.
The US Pathology Market has experienced significant growth over the past few years, driven by advancements in medical technologies, increasing demand for diagnostic services, and the need for precision medicine. Pathology, the study of disease and its effects on the human body, plays a critical role in healthcare. Pathologists are responsible for diagnosing diseases through laboratory tests, helping to determine the most effective treatment plans. This market is essential not only for healthcare providers but also for pharmaceutical, biotech, and other related industries.
The types of pathology services in demand are vast. The two main categories are anatomic pathology and clinical pathology. Anatomic pathology focuses on diagnosing diseases through the examination of tissues, while clinical pathology involves the testing of bodily fluids. The demand for both these services has increased due to the rise in chronic diseases such as cancer, cardiovascular conditions, and diabetes, as well as the growing emphasis on preventive healthcare and early disease detection.
Industries such as pharmaceuticals, biotechnology, and medical device companies heavily rely on pathology services. Pharmaceutical and biotech companies use pathology for drug development, clinical trials, and regulatory approvals. As precision medicine continues to gain traction, the demand for pathology services capable of identifying specific biomarkers and genetic mutations is on the rise. Moreover, the medical device industry uses pathology to design better diagnostic tools and improve patient outcomes.
The US Pathology Market is also being shaped by a growing demand for personalized medicine. The requirement for tailored treatments based on genetic and molecular analysis has led to the need for more advanced diagnostic technologies. Automation and artificial intelligence are becoming increasingly important in pathology laboratories, helping to streamline workflows, reduce human error, and speed up diagnostic processes.
Overall, the US pathology market is expanding rapidly, driven by technological advancements, the rise in demand for precision medicine, and the increasing need for accurate disease diagnostics. As industries continue to require more sophisticated and efficient pathology services, this market is expected to thrive in the coming years, with innovations making a significant impact on the future of healthcare diagnostics.
Get an In-Depth Research Analysis of the US Pathology Market Size And Forecast [2025-2032]
Â
Leica Biosystems
Roche(Ventana Medical Systems)
Hamamatsu Photonics
3DHISTECH
Philips
Apollo Enterprise Imaging
XIFIN
Visiopharm
Corista
Huron Digital Pathology
Objective Pathology Services
Indica Labs
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Pathology Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Pathology Market
Anatomical Pathology
Clinical Pathology
Molecular Pathology
Forensic Pathology
Pediatric Pathology
Oncology
Neurology
Cardiology
Infectious Diseases
Autoimmune Diseases
Histopathology
Immunohistochemistry
Microbiology Techniques
Molecular Diagnostics
Digital Pathology
Hospitals
Diagnostic Laboratories
Research Institutes
Pharmaceutical Companies
Academic Institutions
Biopsy Samples
Surgical Specimens
Blood Samples
Body Fluids
Tissue Samples
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Pathology Market Research Analysis
1. Introduction of the US Pathology Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Pathology Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Pathology Market, By Type
6. US Pathology Market, By Application
7. US Pathology Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Pathology Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/